Pharmaceuticals

Inactivated Vaccines Market Insights: Revenue Expected to Surpass $63.86 Billion by 2029

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the inactivated vaccines market from 2025–2034 with trusted insights from The Business Research Company

What Is The Current Size And Expected Growth Outlook For The Inactivated Vaccines Market?

The prescription orthopedic drugs market size has shown substantial growth in recent years. It is anticipated to expand from $48.41 billion in 2024 to $51.06 billion in 2025, at a compound annual growth rate (CAGR) of 5.5%. This historical growth can be linked to several factors, including an increase in musculoskeletal disorder prevalence, a growing geriatric population, improved awareness regarding osteoporosis treatments, wider healthcare access in developing areas, and a global rise in sports-related injuries.

The prescription orthopedic drugs market size is expected to experience significant growth in the coming years. It is projected to expand to $63.86 billion by 2029, achieving a compound annual growth rate (CAGR) of 5.8%. This anticipated growth during the forecast period can be attributed to factors such as increasing demand for biologics, a growing geriatric population, expanding healthcare access in emerging markets, a rising prevalence of chronic musculoskeletal disorders, and heightened investments in orthopedic drug research and development. Prominent trends for the forecast period include advancements in targeted biologics, the adoption of regenerative medicine therapies, personalized drug formulations, progress in minimally invasive delivery methods, enhanced drug efficacy through gene therapy, innovations in injectable formulations, and innovations in artificial intelligence for drug development and clinical decision-making.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21263&type=smp

Which Growth Drivers Are Propelling The Inactivated Vaccines Market?

The expanding occurrence of musculoskeletal disorders is projected to propel the expansion of the prescription orthopedic drugs market. Musculoskeletal disorders (MSDs) are defined as ailments and injuries impacting the mobility and operation of the human musculoskeletal system, encompassing muscles, tendons, ligaments, nerves, and joints, leading to discomfort and diminished movement. This rising prevalence of musculoskeletal disorders stems mainly from elements such as aging populations, work-related tasks involving repetitive actions and uncomfortable stances, lifestyle decisions like a lack of physical activity and inadequate diet, and inherent genetic factors. Prescription orthopedic drugs are crucial for managing these conditions, as they help ease pain, lessen inflammation, and support the healing process, consequently enhancing mobility and general well-being. For example, data from March 2023, provided by the Office for Health Improvement and Disparities, a UK-based public health governmental body, indicated that in 2022, 17.6% of individuals aged 16 and above reported experiencing a chronic musculoskeletal (MSK) condition, like arthritis or persistent back or joint issues, an increase from 17.0% in 2021. Furthermore, in July 2022, the World Health Organization, an intergovernmental entity based in Switzerland, reported that approximately 1.71 billion individuals globally are afflicted with musculoskeletal disorders. Consequently, the rising prevalence of musculoskeletal disorders is propelling the expansion of the prescription orthopedic drugs market.

Which Segmentation Factors Are Most Significant In The Inactivated Vaccines Market Analysis?

The prescription orthopedic drugs market covered in this report is segmented –

1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Other Drug Types

2) By Application: Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Other Applications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Indomethacin

2) By Opioids: Morphine, Oxycodone, Hydrocodone, Fentanyl, Tramadol

3) By Corticosteroids: Prednisone, Methylprednisolone, Dexamethasone, Hydrocortisone, Betamethasone

4) By Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate, Hydroxychloroquine, Leflunomide, Sulfasalazine, Azathioprine

5) By Other Drug Types: Bisphosphonates, Calcitonin, Monoclonal Antibodies, Muscle Relaxants, Hyaluronic Acid Injections

What New Opportunities Are Emerging From Trends In The Inactivated Vaccines Market?

Companies involved in the prescription orthopedic drugs market are concentrating on broadening the indications for their medications to expand their market reach, improve patient results, and address unmet medical needs in various orthopedic conditions. For example, in January 2023, Heron Therapeutics Inc., a US-based biotechnology company, secured FDA approval for the expanded application of ZYNRELEF (bupivacaine and meloxicam) in soft tissue and orthopedic procedures, including foot and ankle surgeries. This unique extended-release solution is formulated to offer lasting pain relief for up to 72 hours, thereby minimizing or removing the need for opioids following surgery. The broadened indication now encompasses additional orthopedic and soft tissue procedures, such as foot and ankle surgeries, enhancing its relevance in clinical settings. Its innovative dual-drug formulation provides both local anesthetic and anti-inflammatory effects, making it a comprehensive choice for managing post-operative pain with improved patient outcomes.

Who Are The Most Influential Companies In The Inactivated Vaccines Market?

Major companies operating in the prescription orthopedic drugs market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck KGaA, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GSK Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Biogen Inc., UCB S.A., Allergan plc, Penardo Biotech Pvt. Ltd., Horizon Therapeutics plc

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/prescription-orthopedic-drugs-global-market-report

Which Region Holds The Largest Share In The Inactivated Vaccines Market Today?

North America was the largest region in the prescription orthopedic drugs market in 2024. The regions covered in the prescription orthopedic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=21263&type=smp

Browse Through More Reports Similar to the Global Inactivated Vaccines Market 2025, By The Business Research Company

Dermatology Medical Lasers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-medical-lasers-global-market-report

Dermatology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-devices-global-market-report

Veterinary Dermatology Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-dermatology-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795